S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|FDA Approves MOVANTIK™ (naloxegol) Tablets C-II for the Treatment of Opioid-Induced Constipation in Adult Patients with Chronic Non-Cancer Pain|
|Eli Lilly agrees to co-develop AstraZeneca's Alzheimer's treatment|
|BRILINTA Preferred Over Clopidogrel in 2014 AHA/ACC Guideline for the Management of Non–ST-Elevation Acute Coronary Syndromes|
|U.S. FDA Approves Once-Daily XIGDUO™ XR Tablets for Adults with Type 2 Diabetes|
|AstraZeneca Presents Data from Phase III Studies of Lesinurad in Combination with Allopurinol in Gout Patients at American College of Rheumatology 2014 Annual Meeting|
|AstraZeneca Announces Initiation of Development Program for BRILINTA (ticagrelor) Reversal Agent|
|AstraZeneca New Drug Application For IRESSA Accepted By US FDA (2014/12/2)|
|Eli Lilly, AstraZeneca launch patient trial for Alzheimer's treatment|
Click above to view more mutual fund data and stats for azn - Arcturus Ventures Inc.